Cancer Patients Moving To England To Access Treatments
5/04/2013
Clinicians considering the same and have concerns for the future of cancer care in Scotland New research from a survey of oncologists and haematologists in Scotland* has revealed that over a third (39%) are aware of cancer patients who have relocated to England to receive treatment...
Deaths From Prostate Cancer Lower Among Statin Users
5/04/2013
New research from the US suggests men with prostate cancer who took or started taking statins before their diagnosis, may reduce their risk of dying from the disease. Statins are a class of drugs prescribed for lowering cholesterol. Lead researcher Janet L. Stanford, of Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, Washington, and colleagues...
Routine PSA Tests No Longer Recommended - American Urological Association
5/04/2013
Members of the American Urological Association (AUA) recently got together and made a series of new recommendations concerning prostate cancer screening. They now discourage screening men who are at average-risk under the age 55. The AUA says that men should be particularly cautious before making the decision to go through with the screening and weigh the benefits against the potential harms...
More Younger Women Getting Breast Cancer
5/04/2013
The number of younger women (aged under 50) being diagnosed with breast cancer has topped 10,000 in one year for the first time in the United Kingdom, says Cancer Research UK, a charity. Today in the UK, out of every five women who are diagnosed with breast cancer, one is aged under 50 years. Each year nearly 50,000 breast cancer diagnoses are made...
Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results Eventus Diagnostics, Inc. (EventusDx) have announced that it has received CE mark designation for its Octava PinkTM breast cancer test intended for confirmatory use in women who have received negative mammography results...
A Blood Sample Predicts If Cancer Patients Respond To Therapy
5/04/2013
Karolinska Institutet and University Hospital have shown that a simple blood test can predict breast cancer patients response to therapy, how long treatment will be effective and survival. The results are being presented at the IMPAKT scientific conference in Brussels, May 2-4...
AUA Releases New Clinical Guideline On Prostate Cancer Screening
5/03/2013
Men ages 55 to 69 urged to talk with their doctors about benefits, harms of testing Men ages 55 to 69 who are considering prostate cancer screening should talk with their doctors about the benefits and harms of testing and proceed based on their personal values and preferences, according to a new clinical practice guideline released today by the American Urological Association (AUA)...
Researchers Identify Mutations That Cause Blood Cancer Acute Myeloid Leukemia (AML)
5/03/2013
A group of researchers has just identified all of the genetic mutations that cause blood cancer acute myeloid leukemia (AML), which could help drive further research for newer and better treatments for AML. The research, which was published online in The New England Journal of Medicine, could help base treatments for AML according to the genetic profile of the patient's cancer...
Deaths From Prostate Cancer Lower Among Statin Users
5/03/2013
New research from the US suggests men with prostate cancer who took or started taking statins before their diagnosis, may reduce their risk of dying from the disease. Statins are a class of drugs prescribed for lowering cholesterol. Lead researcher Janet L. Stanford, of Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, Washington, and colleagues...
Cook Medical has received CE Mark approval for its PVA Foam Embolization Particles to be used for the treatment of symptomatic benign prostatic hyperplasia (BPH). The product will be shown at this year's Global Embolization Symposium and Technologies (GEST) conference in Prague, Czech Republic, on 1-4 May...